Top 20 Prescription Drugs of 2025
Shots: Rank Drug 2023 Total Revenue ($B) 2024 Total Revenue ($B) Percent Change (%) 1 Keytruda 25.01 29.48 17.87 2…
Read article →
AstraZeneca Reports the US FDA Approval of Koselugo (Selumetinib) for Treating Neurofibromatosis Type 1
Shots: Ref: AstraZeneca | Image: AstraZeneca | Press Release Related News:- AstraZeneca Reports P-III (NATRON) Trial…
Read article →
Alvotech and Advanz Pharma’s Gobivaz (Biosimilar, Simponi) Receives the EC Approval to Treat Several Chronic Inflammatory Diseases
Shots: Ref: Alvotech| Image: Alvotech & Advanz Pharma | Press Release Related News:- Alvotech & Advanz Pharma’s…
Read article →
PharmaShots Magazine-November-2025 Edition
Get a chance to advertise with us! Send us your promotional pieces at [email protected] The post PharmaShots…
Read article →
Day One Biopharmaceuticals to Acquire Mersana Therapeutics for ~$285M
Shots: Ref: Mersana| Image: Mersana| Press Release Related News:- QIAGEN to Acquire Parse Biosciences for ~$280M…
Read article →
ITM Reports the US FDA’s NDA Acceptance for ¹⁷⁷Lu-edotreotide to Treat Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)
Shots: Ref: ITM | Image: ITM | Press Release Related News:- ITM Reports Topline Data from P-III (COMPETE) Trial of…
Read article →
Neurogene Reports Interim P-I/II Trial Results on NGN-401 to Treat Pediatric Patients with Rett Syndrome
Shots: Ref: Neurogene | Image: Neurogene | Press Release Related News:- Novartis Reports P-III (KALUMA) Trial Data of…
Read article →
Thermo Fisher Scientific’s EXENT System Receives the US FDA’s 510(k) Clearance to Aid Multiple Myeloma Diagnosis
Shots: Ref: Businesswire | Image: Thermo Fisher | Press Release Related News:- Thermo Fisher Scientific to Acquire…
Read article →